Cargando…
ZFYVE21 is a complement-induced Rab5 effector that activates non-canonical NF-κB via phosphoinosotide remodeling of endosomes
Complement promotes vascular inflammation in transplant organ rejection and connective tissue diseases. Here we identify ZFYVE21 as a complement-induced Rab5 effector that induces non-canonical NF-κB in endothelial cells (EC). In response to membrane attack complexes (MAC), ZFYVE21 is post-translati...
Autores principales: | Fang, Caodi, Manes, Thomas D., Liu, Lufang, Liu, Kevin, Qin, Lingfeng, Li, Guangxin, Tobiasova, Zuzana, Kirkiles-Smith, Nancy C., Patel, Manal, Merola, Jonathan, Fu, Whitney, Liu, Rebecca, Xie, Catherine, Tietjen, Gregory T., Nigrovic, Peter A., Tellides, George, Pober, Jordan S., Jane-wit, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529429/ https://www.ncbi.nlm.nih.gov/pubmed/31113953 http://dx.doi.org/10.1038/s41467-019-10041-2 |
Ejemplares similares
-
A ZFYVE21-Rubicon-RNF34 signaling complex promotes endosome-associated inflammasome activity in endothelial cells
por: Li, Xue, et al.
Publicado: (2023) -
Author Correction: A ZFYVE21-Rubicon-RNF34 signaling complex promotes endosome-associated inflammasome activity in endothelial cells
por: Li, Xue, et al.
Publicado: (2023) -
Rapamycin antagonizes TNF induction of VCAM-1 on endothelial cells by inhibiting mTORC2
por: Wang, Chen, et al.
Publicado: (2014) -
Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells
por: Cui, Jiajia, et al.
Publicado: (2017) -
Interleukin (IL)-1 promotes allogeneic T cell intimal infiltration and IL-17 production in a model of human artery rejection
por: Rao, Deepak A., et al.
Publicado: (2008)